As a science-led pharmaceutical company, we invest in cutting-edge research to develop new cures for challenging diseases.

We are focused on undertaking dedicated R&D in areas with significant demand. Our research team of over 800 scientists constitutes a quarter of our total workforce. Our systematic approach to the selection of molecules, which involves evaluation of technical, and commercial feasibility data, and customer feedback helps us generate a good return on our research spending. We commercialised 59 products since inception and filed 50 DMFs.

We have a dedicated R&D centre in Hyderabad, which is approved by major regulatory authorities including the USFDA, PMDA and KFDA. The Hyderabad centre is also approved by the Department of Scientific and Industrial Research, Ministry of Science and Technology of India (DSIR). Our R&D centre in Greater Boston, US employs 12 scientists involved in dedicated research to strengthen our Synthesis business.